Multicentric/multifocal breast cancer with a single histotype: Is the biological characterization of all individual FOCI justified?

Annals of Oncology

Volumn 23, Issue 8, 2012, Pages 2042-2046

  Buggi, F ^a   Folli, S ^a   Curcio, A ^a   Casadei Giunchi, D ^a   Rocca, A ^b   Pietri, E ^b   Medri, L ^a   Serra, L ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

Adjuvant therapy; Breast cancer; Invasive; Multicentric disease; Multifocal disease; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE BREAST CANCER WITH A SINGLE HISTOLOGY; MULTIPLE CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84864942671     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr570     Document Type: Article

References (14)

1. Khan SA. The many questions that surround multicentric and multifocal breast cancer. Breast J 2010; 16: 219-221.
2. Cabioglu N, Ozmen V, Kaya H et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg 2009; 208: 67-74.
3. Litton JK, Eralp Y, Gonzalez-Angulo AM et al. Multifocal breast cancer in women < or =35 years old. Cancer 2007; 110: 1445-1450.
4. Andea AA, Bouwman D, Wallis T, Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004; 100: 20-27.
5. Bendifallah S, Werkoff G, Borie-Moutafoff C et al. Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol 2010; 19: e115-e123.
6. Goldhirsch A, Ingle JN, Gelber RD et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009; 20: 1319-1329.
7. Lester SC, Shikha B, Yunn-Yi C et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 2009; 133: 1515-1538.
8. Garimella V, Long ED, O'Kane SL et al. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer. Acta Oncol 2007; 46: 204-207.
9. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
10. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with longterm follow-up. Histopathology 1991; 19: 403-410.
11. Weissenbacher TM, Zschage M, Janni W et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?. Breast Cancer Res Treat 2010; 122: 27-34.
12. Sobin LH, Greene FL. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2003; 97: 1364; author reply 1365.
13. Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol 1995; 26: 965-969.
14. Middleton LP, Vlastos G, Nadeem QM et al. Multicentric mammary carcinoma. Evidence of monoclonal proliferation. Cancer 2002; 94: 1910-1916.